Developmental trajectories in infants and pre-school children with Neurofibromatosis 1

Hannah Slevin1, Fiona Kehinde1, Jannath Begum-Ali2

  • 1Division of Psychology and Mental Health, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Molecular Autism
|October 15, 2024
PubMed

Insights

Children with Neurofibromatosis 1 (NF1) show developmental delays by 24 months, with lower cognitive and adaptive skills and higher autism and ADHD traits compared to typically developing peers. Early monitoring and intervention are crucial for NF1 affected infants.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Genetics

Background:

  • Children with Neurofibromatosis 1 (NF1) exhibit known cognitive, behavioral, and social differences.
  • The precise age and sequence of these developmental differences emerging in NF1 are not fully understood.

Purpose of the Study:

  • To prospectively examine cognitive, behavioral, ADHD trait, and autism symptom development in infants and preschoolers with NF1.
  • To compare developmental trajectories in NF1 children against typically developing (TD) controls.

Main Methods:

  • A prospective cohort study involving 35 children with NF1 and 29 TD children.
  • Standardized cognitive (MSEL) and adaptive behavior (VABS) tests administered from 5 to 36 months.
  • ADHD and autism traits assessed at 24 and 36 months using various standardized measures.

Main Results:

  • Significant differences in cognitive and behavioral developmental trajectories between NF1 and TD groups.
  • NF1 participants showed significantly lower cognitive and adaptive skills at 24 months.
  • NF1 cohort exhibited higher mean autism and ADHD traits at 24 months, with 14% meeting autism criteria by 36 months.

Conclusions:

  • By 24 months, children with NF1 demonstrate impaired cognitive and adaptive skills and elevated autism and ADHD traits compared to TD children.
  • These findings highlight the need for early developmental monitoring and timely intervention referrals for infants with NF1.
Abstract